RANDAL J KIRK Insider Trading for May 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RANDAL J KIRK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of RANDAL J KIRK for May 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15 2017 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Option Exercise | M | 10.37 | 10,000 | 103,700 | 0 | |
| May 15 2017 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | M | 10.37 | 10,000 | 103,700 | 3,562,388 | 3.6 M to 3.6 M (+0.28 %) |
| May 08 2017 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Option Exercise | X | 0.80 | 250,000 | 200,000 | 0 | |
| May 08 2017 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Sell | S | 2.54 | 1,881 | 4,778 | 85,397 | 87.3 K to 85.4 K (-2.16 %) |
| May 08 2017 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Sell | S | 2.70 | 13,893 | 37,511 | 87,278 | 101.2 K to 87.3 K (-13.73 %) |
| May 08 2017 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Sell | S | 2.97 | 2,278 | 6,766 | 101,171 | 103.4 K to 101.2 K (-2.20 %) |
| May 08 2017 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Sell | S | 2.54 | 9,695 | 24,625 | 440,418 | 450.1 K to 440.4 K (-2.15 %) |
| May 08 2017 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Sell | S | 2.70 | 71,607 | 193,339 | 450,113 | 521.7 K to 450.1 K (-13.73 %) |
| May 08 2017 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Sell | S | 2.97 | 11,739 | 34,865 | 521,720 | 533.5 K to 521.7 K (-2.20 %) |
| May 08 2017 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Sell | S | 4.01 | 49,875 | 199,999 | 533,459 | 583.3 K to 533.5 K (-8.55 %) |
| May 08 2017 | XON | INTREXON CORP | KIRK RANDAL J | 10% Owner | Buy | X | 0.80 | 250,000 | 200,000 | 583,334 | 333.3 K to 583.3 K (+75.00 %) |
| May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Option Exercise | X | 0.80 | 250,000 | 200,000 | 0 | |
| May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Sell | S | 2.54 | 1,881 | 4,778 | 85,397 | 87.3 K to 85.4 K (-2.16 %) |
| May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Sell | S | 2.70 | 13,893 | 37,511 | 87,278 | 101.2 K to 87.3 K (-13.73 %) |
| May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Sell | S | 2.97 | 2,278 | 6,766 | 101,171 | 103.4 K to 101.2 K (-2.20 %) |
| May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Sell | S | 2.54 | 9,695 | 24,625 | 440,418 | 450.1 K to 440.4 K (-2.15 %) |
| May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Sell | S | 2.70 | 71,607 | 193,339 | 450,113 | 521.7 K to 450.1 K (-13.73 %) |
| May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Sell | S | 2.97 | 11,739 | 34,865 | 521,720 | 533.5 K to 521.7 K (-2.20 %) |
| May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Sell | S | 4.01 | 49,875 | 199,999 | 533,459 | 583.3 K to 533.5 K (-8.55 %) |
| May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Buy | X | 0.80 | 250,000 | 200,000 | 583,334 | 333.3 K to 583.3 K (+75.00 %) |
| May 08 2017 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Grant | A | 0.00 | 14,135 | 0 | 3,552,388 | 3.5 M to 3.6 M (+0.40 %) |
| May 02 2017 | XON | INTREXON CORP | KIRK RANDAL J | Director | Option Exercise | J | 0.00 | 1,094 | 0 | 110,494 | |
| May 02 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Option Exercise | J | 0.00 | 1,094 | 0 | 110,494 | |
| May 02 2017 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 20.84 | 9,596 | 199,981 | 5,335,131 | 5.3 M to 5.3 M (+0.18 %) |
| May 02 2017 | XON | INTREXON CORP | KIRK RANDAL J | Chief Executive Off ... | Grant | A | 19.67 | 40,671 | 799,999 | 530,442 | 489.8 K to 530.4 K (+8.30 %) |